USPatentGranted
B2

Zn2+-chelating motif-tethered short-chain fatty acids as a novel class of histone deacetylase inhibitors

Granted 19 Apr 2011 · 12 office actions

Life of the patent

23 dated events
⤢ drag to zoom20042006200820102012201420162018202020222024ProsecutionTerm & fees
ProsecutionTerm & feeshover for detail · click to open

Abstract

Zn 2+ -chelating motif-tethered fatty acids as histone deacetylase (HDAC) inhibitors. Compounds performed well in in vitro and in vivo tests.

Claims

20 · 12 independent · depth 2
1234567891011121314151617181920
20 granted claims

Classifications

4 codes
IPC · International Patent Classification
Section A — Human necessities
  • A61K31/19
Section C — Chemistry; metallurgy
  • C07C233/00
USPC · US Patent Classification
514/575564/123

Claim changes

Soon
Coming soonHow the claims changed between publication and grant

See which claims were amended, added or cancelled during examination, with every added and removed word marked.

AmendedAddedCancelledUnchanged

The published claims of this patent are not paired with the granted ones in what we hold.

File wrapper

⤢ drag to zoom2005200620072008200920102011USPTOApplicantNon-final rejectionFinal rejectionResponse after non-finalRequest for continued examination
USPTOApplicanthover for detail · click to open
Pendency
6.4 y
2,330 days filing → grant
Office actions
6
non-final + final
Responses
6
2 RCE
Interviews
1
examiner interview summaries
Examiner
Taylor Victor Oh
art unit 1625 · TC 1600
Citations: 68 back · 0 forward

See the full prosecution history — every USPTO and applicant action on this file, in order.

Log in to unlock

Term & fees

See the term timeline — pendency span, in-force span, the maintenance fees paid and both computed expiry dates.

Log in to unlock

Priority chain

2 priority documents
Priority
2 Dec 2003
earliest claimed
›Priority documents — 2
TypeDocumentDate
provisionalUS 605263482 Dec 2003
related publicationUS 20070225373 A127 Sep 2007

Validity challenges

See the validity challenges on record — reexaminations, IPRs and PGRs, with their institution decisions and outcomes.

Log in to unlock

Citations

See every patent this one cites and every patent that cites it back — publication, assignee, and how each one was found.

Log in to unlock